Improved quality of life after lamivudine dose adjustment in HIV-associated nephropathy with ESKD: A case report from Tanzania

Huda Al Akrabia

Abstract
HIV-associated nephropathy (HIVAN) can progress to end-stage kidney disease(ESKD), complicating antiretroviral therapy (ART) management due to renal dosing requirements,particularly for lamivudine.